Vardenafil Hydrochloride
C
23
H
32
N
6O4S·HCl·3H2O
579.11
Piperazine, 1-[[3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxyphenyl]sulfonyl]-4-ethyl-, monohydrochloride, trihydrate-;
2-[2-Ethoxy-5-(4-ethyl-piperazine-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one, hydrochloride, trihydrate
[330808-88-3] Anhydrous 525.06
[224785-91-5]
Piperazine, 1-[[3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxyphenyl]sulfonyl]-4-ethyl-, monohydrochloride, trihydrate-;
2-[2-Ethoxy-5-(4-ethyl-piperazine-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one, hydrochloride, trihydrate
[330808-88-3] Anhydrous 525.06
[224785-91-5]
DEFINITION
Vardenafil Hydrochloride contains NLT 98.0% and NMT 102.0% of vardenafil hydrochloride (C23H32N6O4S·HCl), calculated on the anhydrous basis.
USP REFERENCE STANDARDS FOR PURCHASE
USP Vardenafil Hydrochloride RSUSP Vardenafil System Suitability RS